Journal of Health Services Research & Policy > Volume 13, Number 2 > Pp. 85-91

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Karnon, J. Articles by Tappenden, P. PubMed PubMed Citation Social Bookmarking                      What's this?

Original research

Modelling the expected net benefits of interventions to reduce the burden of medication errors

Jonathan Karnon , Aileen McIntosh ¹, Joanne Dean ¹, Peter Bath ², Allen Hutchinson ¹, Jeremy Oakley ³, Nicky Thomas ⁴, Peter Pratt ⁵, Louise Freeman-Parry ⁴, Ben-Tzion Karsh ⁶, Tejal Gandhi ⁷, Paul Tappenden

Department of Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, UK; ¹ Department of Public Health, School of Health and Related Research, University of Sheffield, UK; ² Department of Information Studies, University of Sheffield, UK; ³ Department of Probability and Statistics, University of Sheffield, UK; ⁴ The Royal Hallamshire Hospital, Glossop Road, Sheffield, UK; ⁵ Michael Carlisle Centre, Sheffield Care Trust, Sheffield, UK; ⁶ University of Wisconsin-Madison, Madison, Wisconsin, USA; ⁷ Brigham and Women's Hospital, Boston, Massachussetts, USA

Correspondence to: j.karnon{at}sheffield.ac.uk

Objectives: The aim of this study is to estimate the potential costs and benefits of three key interventions (computerized physician order entry [CPOE], additional ward pharmacists and bar coding) to help prioritize research to reduce medication errors.

Methods: A generic model structure was developed to describe the incidence and impacts of medication errors in hospitals. The model follows pathways from medication error points at alternative stages of the medication pathway through to the outcomes of undetected errors. The model was populated from a systematic review of the medication errors literature combined with novel probabilistic calibration methods. Cost ranges were applied to the interventions, the treatment of preventable adverse drug events (pADEs), and the value of the health lost as a result of an ADE.

Results: The model predicts annual health service costs of between £0.3 million and £1 million for the treatment of pADEs in a 400-bed acute hospital in the UK. Including only health service costs, it is uncertain whether any of the three interventions will produce positive net benefits, particularly if high intervention costs are assumed. When the monetary value of lost health is included, all three interventions have a high probability of producing positive net benefits with a mean estimate of around £31.5 million for CPOE over a five-year time horizon.

Conclusions: The results identify the potential cost-effectiveness of interventions aimed at medication errors, as well as identifying key drivers of cost-effectiveness that should be specifically addressed in the design of primary evaluations of medication error interventions.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?